July 4th 2024 – Join us this week as we feature Stephanie Willerth, Co-Founder and CEO of Axolotl Biosciences, based in Victoria, BC. Stephanie and her team specialize in 3D tissue printing and developing bioinks for neural and cardiac tissues. We’ll delve into the potential applications of 3D tissue printing in personalized medicine, the growth of this innovative field, and Stephanie's advice for entrepreneurs looking to expand their businesses.

Axolotl Biosciences: axolotlbiosciences.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com

Lab Occupier: laboccupier.com

June 27th 2024 – Join us this week as we speak with Kevin Neil and Jean-François Millau from Tatum Bioscience in Sherbrooke, Quebec. Kevin and Jean-François are a part of a team that are ‘programming’ bacteria to turn them into cancer-fighting drugs and the work they are doing is cutting edge.

TATUM Bioscience: tatumbio.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com

Lab Occupier: laboccupier.com

June 20th 2024 – This week, we are excited to welcome Andrew Cordssen-David from HeadFirst, a company based in Kitchener, Ontario. Andrew and his team are pioneering the first-ever concussion detection system using a rapid test, akin to the Covid rapid tests.

HeadFirst: headfirstdx.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com

Lab Occupier: laboccupier.com